Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 5 - Drugs for disorders of the endocrine system
Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908)
07/2012
07/05/2012US20120171233 Peptide inhibitors for mediating stress responses
07/04/2012EP2471533A1 Aryl carbonyl derivatives as therapeutic agents
07/04/2012EP2471378A1 Compositions and methods for preventing or treating cardiovascular diseases in felines with hyperthyroidism
07/04/2012EP2470530A1 Heterocyclic-substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof
07/04/2012EP1487805B1 Pyrimidine derivatives
07/04/2012CN1964703B Immediate release pharmaceutical tablets with height greater than width
07/04/2012CN1829738B Novel insulin derivatives
07/04/2012CN102548964A Etomidate analogues that do not inhibit adrenocortical steroid synthesis
07/04/2012CN102532099A Composition, synthesis and application of hydantoin derivatives
07/04/2012CN102532073A Ethylene derivative serving as selective estrogen receptor modulators (SERMs)
07/04/2012CN102526702A Small peptide trefoil factor family 3 (TFF3) for curing metabolic syndrome
07/04/2012CN102526700A Octreotide acetate freeze-dried combination for injection and preparation method thereof
07/04/2012CN102526592A Chinese medicinal composition for preventing and treating cardiovascular and cerebrovascular diseases and immune dysfunction
07/04/2012CN102526500A Application of dendrobium water extract to preparation of estrogen medicines
07/04/2012CN102526315A Preparation method of extracts of effective fractions of lychee seeds
07/04/2012CN102526165A Rhodiola effective fractions, preparation method, drug composition and uses thereof
07/04/2012CN102526164A Traditional Chinese medicine composition for preventing insulin resistance and related metabolic syndrome thereof
07/04/2012CN102526127A Flash type extraction method for active constituents in cordyceps militaris
07/04/2012CN102525927A Octreotide acetate preparation and preparation method thereof
07/04/2012CN102525914A Injection sustained-release preparation of LHRH (luteinizing hormone releasing hormone) antagonist substance and preparation thereof
07/04/2012CN101972245B Composition capable of promoting insulin secretion and inhibiting generation of advanced glycosylation end products
07/04/2012CN101897687B New application of sodium valproate in treating liver inflammation related disease
07/04/2012CN101801388B Transdermally absorbable preparation
07/04/2012CN101781273B Dipeptidylpeptidase IV inhibitor containing guanidyl
07/04/2012CN101652476B Anti-FGF23 antibody and pharmaceutical composition comprising the same
07/04/2012CN101619088B Maslinic acid derivative as well as preparation and application thereof
07/04/2012CN101601652B Momestasone furoate lipidosome cream
07/03/2012US8212040 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and thereof
07/03/2012CA2409647C Methods of treating androgen deficiency in men using selective antiestrogens
07/03/2012CA2394086C 4-aminopiperidine derivatives and their use as medicine
06/2012
06/28/2012WO2012087389A1 Novel 19-nor-steroids and their use for treating progesterone-dependent conditions
06/28/2012WO2012084711A1 N-substituted azetidine derivatives
06/28/2012WO2012013331A3 Capsules of active pharmaceutical ingredients and polyunsaturated fatty acids for the treatment of prostate diseases
06/28/2012US20120165372 Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
06/28/2012US20120165362 Androgen receptor modulator compounds and methods
06/28/2012US20120165337 Tetrahydroquinoxaline urea derivatives, preparation thereof, and therapeutic use thereof
06/28/2012US20120165330 Quinazolinone and related analogs as sirtuin modulators
06/28/2012US20120164122 Phytoestrogenic formulations for alleviation or prevention of neurodegenerative diseases
06/28/2012US20120164114 Treatment of immune-related diseases and disorders using amnion derived adherent cells
06/28/2012CA2821807A1 Methods and compositions suitable for managing blood glucose in animals
06/28/2012CA2820877A1 Novel 19-nor-steroids and their use for treating progesterone-dependent conditions
06/28/2012CA2819299A1 N-substituted azetidine derivatives
06/27/2012EP1991559B1 Oxa-steroids derivatives as selective progesterone receptor modulators
06/27/2012EP1989217B1 11-phosphorous steroid derivatives useful as progesterone receptor modulators
06/27/2012EP1698624B1 Phenylpropanoic acid derivatives
06/27/2012CN102512688A Nilestriol-beta-cyclodextrin inclusion compound and preparation method thereof
06/27/2012CN102512503A Separation method for flavonoid substances of Chinese toon leaves
06/27/2012CN102512403A Application of honokiol in pharmacy, and medicine used for treating type II diabetes mellitus
06/27/2012CN102205074B Chinese medicinal composition and application thereof
06/27/2012CN101843842B Medicament for treating hypothyroidism
06/27/2012CN101077350B Compostion and method of treating gonad dysfunction
06/27/2012CN101022822B Liquid preparation of physiologically active peptide
06/26/2012US8207194 Compounds having a 4-pyridylalkylthio group as a substituent
06/26/2012US8207149 Method for treating secondary hyperparathyroidism in CKD
06/26/2012US8206947 Human transmembrane proteins
06/26/2012US8206727 Oral suspension of prednisolone acetate
06/26/2012US8206723 having structurally modified terminal ends which confers enhanced half-life and biological activity for use in prevention and treatment of neuromuscular and pain disorders; cosmetics
06/21/2012WO2012083112A2 Cyp11b, cyp17, and/or cyp21 inhibitors
06/21/2012WO2012081692A1 Pyrazole derivative
06/21/2012WO2012081570A1 Lactam compound or a salt thereof, and ppar activator
06/21/2012WO2012080831A1 Composition for the treatment of metabolic disorders
06/21/2012WO2012080284A2 Substituted 6,6-fused nitrogenous heterocyclic compounds and uses thereof
06/21/2012WO2012079154A1 Selective estrogen receptor modulators
06/21/2012US20120157424 Treatment of menopause-associated symptoms
06/21/2012US20120157421 17Beta-Alkyl-17Alpha-oxy-estratrienes
06/21/2012US20120156301 Methods and Compositions for Treating and Preventing Symptoms of Hormonal Variations
06/21/2012CA2821893A1 Pyrazole derivative
06/21/2012CA2819515A1 Cyp11b, cyp17, and/or cyp21 inhibitors
06/21/2012CA2817460A1 Substituted 6,6-fused nitrogenous heterocyclic compounds and uses thereof
06/20/2012EP2465524A1 Autoantibody production inhibitor
06/20/2012EP2465519A1 Treatment of endothelial dysfunction in diabetic patients
06/20/2012EP2297177B1 C-ring-substituted pregn-4-ene-21,17-carbolactone, and pharmaceutical preparations comprising the latter
06/20/2012EP1960347B1 17-beta-hydroxysteroid dehydrogenase type 3 (17beta-hsd3) inhibitors
06/20/2012EP1467705B1 Therapeutic agent delivery tampon
06/20/2012CN102504024A Antibodies that bind human interleukin-18 and methods of making and using
06/20/2012CN102503891A Pyrazole derivatives as 11-beta-hsd1 inhibitors
06/20/2012CN101935656B Gene for promoting insulin secretion, preparation method and application thereof
06/19/2012US8202838 Methods for treatment of headaches by administration of oxytocin
06/19/2012CA2522784C Antiandrogens with marginal agonist activity and methods of use
06/19/2012CA2349202C Method of preparing stable suspensions of insoluble microparticles
06/14/2012US20120149729 Metalloenzyme inhibitor compounds
06/14/2012US20120149682 Heterocyclic-substituted pyrrolopyridines and pyrrolopyrimidines as jak inhibitors
06/14/2012US20120149681 Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as jak inhibitors
06/14/2012US20120149671 17alpha, 21-dihydroxypregnene esters as antiandrogenic agents
06/14/2012US20120149644 Compositions and methods for treating growth hormone deficiency
06/14/2012US20120149638 Methods for preventing or treating insulin resistance
06/14/2012US20120148684 Methods useful in the treatment of bone resorption diseases
06/14/2012US20120148675 Testosterone undecanoate compositions
06/14/2012US20120148654 Method and system for a photoresist-based immunoisolative microcontainer with nanoslots defined by nanoimprint lithography
06/14/2012US20120148566 Product and method for treatment of conditions associated with receptor-desensitization
06/14/2012US20120148540 Proliferated cell lines and uses thereof
06/13/2012EP2463290A1 Thienooxazepine derivative
06/13/2012EP2462154A2 Novel crystal form of cdb-4124 and process for the preparation thereof
06/13/2012EP2461831A1 Growth hormones with prolonged in-vivo efficacy
06/13/2012EP2461820A1 Orally administerable pharmaceutical preparation containing insulin
06/13/2012EP2461804A2 Greater utility with thyroid hormone
06/13/2012EP1740213B9 Liquid growth hormone formulation
06/13/2012EP1495053B1 Angiopoietin-2 and angiopoietin-1 specific binding agents
06/13/2012EP1235594B1 Inhibition of secretion from non-neuronal cells
06/13/2012CN1483831B Process for obtaining insulin and insulin derivatives having correctly bonded crystine bridges
1 ... 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 ... 290